Jim Cramer's Mad Money Lightning Round Picks, 8/3/07 [View article]
August 8th The stock has moved way too much on RNAi hype and very early pre-clinical and Phase I data for big targets such as obesity. They just raised a lot of money, hit the stock price, and they are going to have to do it again in a year or so at the rate they are burning money. The company will have to strike a major deal to see a major upside move in the stock. A marketing deal, that is -- big Pharma does not buy drug delivery companies. I believe fund managers are taking advantage of 19 Touts by Cramer then will short the stock and cash in Big time. Maybe not a conspiracy but shareholders are left in the dust all the time! Their statistics page is a disaster and they have to jump many hurdles with RNAI with FDA, Good Luck, you get what you pay for. NO PRODUCTS!
Jim Cramer's Mad Money Lightning Round Picks, 8/3/07 [View article]
Aug.6th,2007 Cramer touts NSTK for the 19th time but who's counting! Yea buy it before Wednesday's dismal earnings report. You want a good chance of speculation with a company that boasts a better statistics page than NSTK, then buy VPHM. It will do far better in next 10months than nstk. Overpriced stock nstk compared to sales! Other companies are doing well in phase trials with obesity and nstk is just what Cramer says"HOPE" All I know is I HOPE you purchase something else because nstk is not what it appears to be in my opinion!
Jim Cramer's Mad Money Lightning Round Picks, 8/3/07 [View article]
The stock has moved way too much on RNAi hype and very early pre-clinical and Phase I data for big targets such as obesity. They just raised a lot of money, hit the stock price, and they are going to have to do it again in a
year or so at the rate they are burning money. The company will have to
strike a major deal to see a major upside move in the stock. A
marketing deal, that is -- big Pharma does not buy drug delivery companies.
I believe fund managers are taking advantage of 19 Touts by Cramer then
will short the stock and cash in Big time. Maybe not a conspiracy but shareholders are left in the dust all the time!
Their statistics page is a disaster and they have to jump many hurdles with RNAI with FDA, Good Luck, you get what you pay for. NO PRODUCTS!
Jim Cramer's Mad Money Lightning Round Picks, 8/3/07 [View article]
Yea buy it before Wednesday's dismal earnings report.
You want a good chance of speculation with a company that boasts a better statistics page than NSTK, then buy VPHM. It will do far better in next 10months than nstk.
Overpriced stock nstk compared to sales!
Other companies are doing well in phase trials with obesity and nstk is just what Cramer says"HOPE"
All I know is I HOPE you purchase something else because nstk is not what it appears to be in my opinion!